Journal of Addiction Medicine

Article	Citations
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	76
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	53
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	41
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	41
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	38
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	37
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	36
Letter to the Editor (RE: Polles et al)	35
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	32
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	28
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	26
Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	25
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	25
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	25
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	24
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	23
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	23
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	23
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	22
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	21
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	21
Use of Cannabinoids by People Who Consume Kratom in the United States	19
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	19
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	19
Fentanyl Test Strips for Harm Reduction: A Scoping Review	18

Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	18
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	17
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	17
The Need for Multidisciplinary Hospital Teams for Injection Drug Use-related Infective Endocarditis	17
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	17
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	16
Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	16
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	16
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	15
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	15
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	14
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	14
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	13
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	13
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	12
Current State of Perioperative Buprenorphine Management—A National Provider Survey	12
A Hospital-based Managed Alcohol Program in a Canadian Setting	12
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	12
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	11
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	11
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	11
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	11
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	10
Retention With Medication for Opioid Use Disorder: The Role of the Primary Care Relationship	10
Response to: “Prevalence of Kratom Use Disorder Among Kratom Consumers”	10
Climate Change and the Opioid Epidemic	10
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	10
Letter in Reply	10
Involuntary Commitment for Substance Use: Addiction Care Professionals Must Reject Enabling Coercion and Patient Harm	10
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat among US Adults	10
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	10
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	10
Challenges of Diagnosing and Managing Designer Benzodiazepine Dependence and Withdrawal: A Case Report	10
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	9
Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	9
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	9
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	8
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	8
Letter in Reply	8
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	8
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	8
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	8
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	8
The Difficulties in Finding the Relevant Associations between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	8
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	8
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	7
Complexities in Assessing Pregnancy-related Outcomes Among Patients Receiving Interdisciplinary Treatment for an Opioid Use Disorder	7
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	7
Prevalence of Kratom Use Disorder Among Kratom Consumers	7
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	7

The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	7
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	7
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	7
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	7
Maternal Cannabis Use in the Perinatal Period: Data From the Pregnancy Risk Assessment Monitoring System Marijuana Supplement, 2016–2018	7
Addiction Services for Veterans: Opportunities in Acute Care	7
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	7
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	7
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	7
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	7
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	6
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	6
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	6
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	6
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	6
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	6
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	6
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	6
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	6
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	6
Direct Induction of Buprenorphine Extended-Release: A Case Report	6
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	6
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	6
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	6
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	6
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	6
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	6
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	6
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	5
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	5
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	5
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	5
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	5
The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance	5
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	5
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	5
Response to the Federation of State Physician Health Program's Commentary	5
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	5
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	5
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	5
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	5
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	5
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	5
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	5
Challenges of Drug Testing in Addiction Treatment	5
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	5
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	5
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	5
Response to Martins et al.	5
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	5
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	5
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	5
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	5
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	4
Exploring Preferences for Communication and Care among Hospitalized Patients with Opioid Use Disorder: A Qualitative Descriptive Study	4
Cannabis Use and Stroke: Does a Risk Exist?	4
Buprenorphine-naloxone versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	4
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	4
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	4
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	4
2024 ASAM Annual Conference Poster Abstracts	4
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	4
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	4
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	4
Use of Practices to Reduce of Sudden Unexpected Infant Death among Caregivers of Opioid Exposed Newborns	4
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	4
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	4
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	4
A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic	4
Circumstances Around Cigarette Use After Enforced Abstinence From Smoking in an American Prison	4
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	4
Does Labetalol Trigger False Positive Drug Testing Results?	4
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	4
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	4
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	4
The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup	4
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	4
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	4

Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	4
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	4
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	4
Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients	3
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	3
Effectiveness of and Access to Medications for Opioid Use Disorder for Adolescents and Young Adults: A Scoping Review	3
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	3
The Use of Extended-Release Buprenorphine in the Treatment of Adolescent Opioid Use Disorder: A Case Series	3
Early Long-Acting Buprenorphine for Opioid Use Disorder in the Setting of Acute Pain	3
Facilitating Integrated Perinatal Care for Families Affected by Substance Use	3
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication–related Mortality	3
Factors Associated With the Presence of Co-occurring Pain and Substance Use Disorder Programs in Substance Use Treatment Facilities	3
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone	3
Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder	3
Response to Avoiding NICU Transfer for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit	3
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	3
Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis	3
Medication for Opioid Use Disorder for Hospitalized Patients at Six New York City Public Hospitals with an Addiction Consult Service	3
Privacy and Digital Health: Causes for Concern and a Way Forward	3
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria	3
Standard Versus Rapid Inpatient Methadone Titration for Pregnant Patients With Opioid Use Disorder: A Retrospective Cohort Study	3
Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques	3
Association Between Smoking Abstinence and Depression and Anxiety Symptoms After Hospital Discharge: The Helping HAND 4 Trial	3
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT	3
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes	3
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes	3
An Open-label Pilot Study of NicoBloc as a Novel Smoking Cessation Intervention	3
Civil Commitment for Substance Use Disorders: A National Survey of Addiction Medicine Physicians	3
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	3
Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit	3
The Prognostic Role of DSM-5 Alcohol Use Disorder Severity and Age of Onset in Treatment Outcome Among Adults Aged 60+	3
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	3
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	3
Expanding Medical Education to Include Substance Use Disorders During Pregnancy and Postpartum: Preliminary Effectiveness of a Pilot Curriculum for Medical Students	3
A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment	3
Isolated Kratom Use Disorder Treated With Extended-Release Buprenorphine Taper	3
National Provider Survey: Use of Naltrexone for Pregnant Individuals with Substance Use Disorders	3
Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series	3
An Attendance-based Contingency Management Pilot Program for Veterans Experiencing Homelessness With Stimulant-associated Cardiomyopathy in Primary Care	3
Integrating Ambulatory Addiction Consultation Service Into a Community Mental Health Center	3
Pandemics Interlaced: The Impact of the COVID-19 Pandemic on the Wellbeing of Sober Living Home Residents	3
Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial	3
Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review	3